Regenxbio
RGNX
RGNX
167 hedge funds and large institutions have $742M invested in Regenxbio in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.34% more ownership
Funds ownership: 85.06% → 85.4% (+0.34%)
4% less funds holding
Funds holding: 174 → 167 (-7)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Holders
167
Holding in Top 10
3
Calls
$4.66M
Puts
$2.11M
Top Buyers
| 1 | +$11M | |
| 2 | +$7.97M | |
| 3 | +$7.71M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$7.67M |
| 5 |
BlackRock
New York
|
+$4.56M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$7.19M | |
| 3 | -$6.08M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.78M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$5.46M |